Modulation of hematopoietic stem cell homing and engraftment by CD26CHRISTOPHERSON, Kent W; HANGOC, Giao; MANTEL, Charlie R et al.Science (Washington, D.C.). 2004, Vol 305, Num 5686, pp 1000-1003, issn 0036-8075, 4 p.Article

Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumorsINAMOTO, Teruo; YAMADA, Taketo; DANG, Nam H et al.Clinical cancer research. 2007, Vol 13, Num 14, pp 4191-4200, issn 1078-0432, 10 p.Article

The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cordKIRALY, Kornél; LAMBEIR, Anne-Marie; SZALAI, Judit et al.European journal of pharmacology. 2011, Vol 650, Num 1, pp 195-199, issn 0014-2999, 5 p.Article

The simpson-golabi-behmel syndrome causative Glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26DAVOODI, Jamshid; KELLY, John; GENDRON, Nathalie H et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 13, pp 2300-2310, issn 1615-9853, 11 p.Article

Circulating levels of soluble CD26 are associated with phobic anxiety in womenEMANUELE, Enzo; MINORETTI, Piercarlo; MARTINELLI, Valentina et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 7, pp 1334-1336, issn 0278-5846, 3 p.Article

Serum levels of soluble CD26 and CD30 in patients on hemodialysisNAKAO, Kazushi; NAGAKE, Yoshio; OKAMOTO, Akira et al.Nephron. 2002, Vol 91, Num 2, pp 215-221, issn 0028-2766Article

Adenosine deaminase in rodent median eminence : Detection by antibody to the mouse enzyme and co-localization with adenosine deaminase-complexing protein (CD26)NAGY, J. I; YAMAMOTO, T; UEMURA, H et al.Neuroscience. 1996, Vol 73, Num 2, pp 459-472, issn 0306-4522, 13 p.Article

Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantationKAMEOKA, J; SATO, T; TORIMOTO, Y et al.Blood. 1995, Vol 85, Num 4, pp 1132-1137, issn 0006-4971Article

Circulating CD26 is egatively associated with inflammation in human and experimental arthritisBUSSO, Nathalie; WAGTMANN, Nicolai; HERLING, Christian et al.The American journal of pathology. 2005, Vol 166, Num 2, pp 433-442, issn 0002-9440, 10 p.Article

Targeting of an activated T-cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD26DUKE-COHAN, J. S; MORIMOTO, C; SCHLOSSMAN, S. F et al.Blood. 1993, Vol 82, Num 7, pp 2224-2234, issn 0006-4971Article

Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytesDE MEESTER, I; VANHOOF, G; HENDRIKS, D et al.Clinica chimica acta. 1992, Vol 210, Num 1-2, pp 23-34, issn 0009-8981Article

CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. CommentaryBROXMEYER, Hal E; PERANTEAU, William H; ENDO, Masayuki et al.Blood. 2006, Vol 108, Num 13, issn 0006-4971, 3966,4268-4274 [8 p.]Article

CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes MellitusSANG AH LEE; YOUNG REE KIM; KOH, Gwanpyo et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 6, pp 2553-2561, issn 0021-972X, 9 p.Article

CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural MesotheliomaAOE, Keisuke; JEET AMATYA, Vishwa; INAI, Kouki et al.Clinical cancer research (Print). 2012, Vol 18, Num 5, pp 1447-1456, issn 1078-0432, 10 p.Article

The Effect of Organ-Specific CD26/DPP IV Enzymatic Activity Inhibitor-Preconditioning on Acute Pulmonary Allograft RejectionJUNGRAITHMAYR, Wolfgang; OBERREITER, Birgit; KOROM, Stephan et al.Transplantation. 2009, Vol 88, Num 4, pp 478-485, issn 0041-1337, 8 p.Article

Orally active antiviral tripeptide glycyl-prolyl-glycinamide is activated by CD26 (dipeptidyl peptidase IV) before transport across the intestinal epitheliumHUBATSCH, Ina; LAZOROVA, Lucia; VAHLNE, Anders et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1087-1092, issn 0066-4804, 6 p.Article

Is CD95 or CD26 expression on T-cells a marker for HIV non- or slow-progressor status ?HARR, T; VON OVERBECK, J; BATTEGAY, M et al.Clinical microbiology and infection. 1998, Vol 4, Num 8, pp 464-465, issn 1198-743XArticle

Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy : implications for the use of CD26 as a surrogate marker of a human Th1-like reactionSEITZER, U; SCHEEL-TOELLNER, D; MATTERN, T et al.Virchows Archiv. 1998, Vol 432, Num 4, pp 343-347, issn 0945-6317Article

CD26 and CD31 surface antigen expression on human colostral T cellsBERTOTTO, A; SPINOZZI, F; BARTOLUCCI, M et al.Biology of the neonate. 1995, Vol 68, Num 4, pp 259-263, issn 0006-3126Article

Activation of cord T lymphocytes. IV: Analysis of surface expression and functional role of 1F7 (CD26) moleculeGERLI, R; AGEA, E; MUSCAT, C et al.Cellular immunology (Print). 1994, Vol 155, Num 1, pp 205-218, issn 0008-8749Article

Direct association of adenosine deaminase with a T cell activation antigen, CD26KAMEOKA, J; TANAKA, T; NOJIMA, Y et al.Science (Washington, D.C.). 1993, Vol 261, Num 5120, pp 466-469, issn 0036-8075Article

CD26/dipeptidyl-peptidase IV in psoriatic skin : upregulation and topographical changesVAN LINGEN, R. G; VAN DE KERKHOF, P. C. M; SEYGER, M. M. B et al.British journal of dermatology (1951). 2008, Vol 158, Num 6, pp 1264-1272, issn 0007-0963, 9 p.Article

Effects of topical calcipotriol on the expression of adhesion molecules in psoriasisSAVOIA, P; NOVELLI, M; DE MATTEIS, A et al.Journal of cutaneous pathology. 1998, Vol 25, Num 2, pp 89-94, issn 0303-6987Article

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IVTANAKA, T; DUKE-COHAN, J. S; KAMEOKA, J et al.Proceedings of the National Academy of Sciences of the United States of America. 1994, Vol 91, Num 8, pp 3082-3086, issn 0027-8424Article

Dipeptidyl peptidase IV (CD26): expression, structure and functions in lymphocytesMARGUET, D; DAVID, F; VIVIER, I et al.Advances in neuroimmunology. 1993, Vol 3, Num 3, pp 209-215, issn 0960-5428Article